GB0217294D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB0217294D0
GB0217294D0 GBGB0217294.8A GB0217294A GB0217294D0 GB 0217294 D0 GB0217294 D0 GB 0217294D0 GB 0217294 A GB0217294 A GB 0217294A GB 0217294 D0 GB0217294 D0 GB 0217294D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
derivatives
mammals
useful
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0217294.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0217294.8A priority Critical patent/GB0217294D0/en
Publication of GB0217294D0 publication Critical patent/GB0217294D0/en
Priority to JP2004526773A priority patent/JP4515260B2/ja
Priority to AT03784064T priority patent/ATE336995T1/de
Priority to US10/522,058 priority patent/US20060040925A1/en
Priority to EP03784064A priority patent/EP1539133B1/en
Priority to PCT/EP2003/008153 priority patent/WO2004014361A1/en
Priority to ES03784064T priority patent/ES2270142T3/es
Priority to DE60307860T priority patent/DE60307860T2/de
Priority to AU2003251474A priority patent/AU2003251474A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
GBGB0217294.8A 2002-07-25 2002-07-25 Medicaments Ceased GB0217294D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0217294.8A GB0217294D0 (en) 2002-07-25 2002-07-25 Medicaments
JP2004526773A JP4515260B2 (ja) 2002-07-25 2003-07-23 アミノシクロヘキセンキノリンおよび抗菌活性を有するそのアザアイソステリック類似体
AT03784064T ATE336995T1 (de) 2002-07-25 2003-07-23 Aminocyclohexenchinoline und ihre azaisosterischen analoga mit antibakterieller wirkung
US10/522,058 US20060040925A1 (en) 2002-07-25 2003-07-23 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
EP03784064A EP1539133B1 (en) 2002-07-25 2003-07-23 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
PCT/EP2003/008153 WO2004014361A1 (en) 2002-07-25 2003-07-23 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
ES03784064T ES2270142T3 (es) 2002-07-25 2003-07-23 Aminociclohexano quinolinas y sus analogos azaisostericos con actividad antibacteriana.
DE60307860T DE60307860T2 (de) 2002-07-25 2003-07-23 Aminocyclohexenchinoline und ihre azaisosterischen Analoga mit antibakterieller Wirkung
AU2003251474A AU2003251474A1 (en) 2002-07-25 2003-07-23 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0217294.8A GB0217294D0 (en) 2002-07-25 2002-07-25 Medicaments

Publications (1)

Publication Number Publication Date
GB0217294D0 true GB0217294D0 (en) 2002-09-04

Family

ID=9941121

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0217294.8A Ceased GB0217294D0 (en) 2002-07-25 2002-07-25 Medicaments

Country Status (9)

Country Link
US (1) US20060040925A1 (https=)
EP (1) EP1539133B1 (https=)
JP (1) JP4515260B2 (https=)
AT (1) ATE336995T1 (https=)
AU (1) AU2003251474A1 (https=)
DE (1) DE60307860T2 (https=)
ES (1) ES2270142T3 (https=)
GB (1) GB0217294D0 (https=)
WO (1) WO2004014361A1 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
EP1470131A2 (en) 2002-01-29 2004-10-27 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
US7312212B2 (en) 2002-01-29 2007-12-25 Glaxo Group Limited Aminopiperidine derivatives
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
US7232832B2 (en) * 2002-11-05 2007-06-19 Smithkline Beecham Corporation Antibacterial agents
EP1560488B1 (en) 2002-11-05 2010-09-01 Glaxo Group Limited Antibacterial agents
WO2004050036A2 (en) * 2002-12-04 2004-06-17 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
AR042486A1 (es) * 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
WO2006002047A2 (en) 2004-06-15 2006-01-05 Glaxo Group Limited Antibacterial agents
US20080194547A1 (en) * 2004-07-09 2008-08-14 Glaxo Group Limited Antibacterial Agents
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
ATE536351T1 (de) 2006-01-26 2011-12-15 Actelion Pharmaceuticals Ltd Tetrahydropyran-antibiotika
WO2007098214A1 (en) * 2006-02-21 2007-08-30 Amgen Inc. Cinnoline derivatives as phosphodiesterase 10 inhibitors
US20070287707A1 (en) * 2006-02-28 2007-12-13 Arrington Mark P Phosphodiesterase 10 inhibitors
WO2007103554A1 (en) * 2006-03-08 2007-09-13 Amgen Inc. Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
EP2001887B1 (en) 2006-04-06 2010-09-15 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
WO2007118130A2 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Antibacterial agents
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
TW200819457A (en) 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
AU2008240764C1 (en) * 2007-04-20 2011-10-20 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
EP2352734A1 (en) 2008-10-17 2011-08-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
AR089929A1 (es) 2012-02-10 2014-10-01 Actelion Pharmaceuticals Ltd Proceso para manufacturar un derivado de naftiridina
BR112015002493A8 (pt) * 2012-08-30 2019-07-30 Hoffmann La Roche composto, composição farmacêutica, processo para a preparação de uma composição farmacêutica, kit e uso de um composto”
US10702521B2 (en) 2014-08-22 2020-07-07 Glaxosmithkline Intellectual Property Development Limited Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones
TW201718514A (zh) 2015-08-07 2017-06-01 拜耳作物科學股份有限公司 作為殺蟲劑之經２－（雜）芳基取代之稠合雜環衍生物
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
KR20220087497A (ko) 2019-10-18 2022-06-24 더 리전츠 오브 더 유니버시티 오브 캘리포니아 병원성 혈관을 표적화하기 위한 화합물 및 방법
US12590298B2 (en) 2019-10-18 2026-03-31 The Regents Of The University Of California Ex vivo tumor angiogenesis model
CN119161260A (zh) * 2024-06-26 2024-12-20 安徽大学 一种1-（2-氨基-4-氟-5-甲氧基苯基）-1-丙酮的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798383A (en) * 1994-11-10 1998-08-25 Pfizer Inc. Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas
CA2318842A1 (en) * 1998-01-26 1999-07-29 Julie Dorothy Warrack Quinoline derivatives as antibacterials
GB9822450D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
JP2002535323A (ja) * 1999-01-20 2002-10-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー プロテインキナーゼ阻害剤としてのピペリジニルキノリン
GB9914486D0 (en) * 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
GB9917408D0 (en) * 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917406D0 (en) * 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
EP1305308B1 (en) * 2000-07-26 2006-12-20 Smithkline Beecham Plc Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
FR2816618B1 (fr) * 2000-11-15 2002-12-27 Aventis Pharma Sa Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
DE60307860D1 (de) 2006-10-05
WO2004014361A9 (en) 2004-04-08
ATE336995T1 (de) 2006-09-15
EP1539133A1 (en) 2005-06-15
DE60307860T2 (de) 2007-10-11
JP4515260B2 (ja) 2010-07-28
AU2003251474A8 (en) 2004-02-25
EP1539133B1 (en) 2006-08-23
JP2005538125A (ja) 2005-12-15
WO2004014361A1 (en) 2004-02-19
US20060040925A1 (en) 2006-02-23
ES2270142T3 (es) 2007-04-01
AU2003251474A1 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
GB0217294D0 (en) Medicaments
GB0118238D0 (en) Medicaments
GB0112836D0 (en) Medicaments
GB0031088D0 (en) Medicaments
GB0101577D0 (en) Compounds
GB9917406D0 (en) Compounds
MXPA03000708A (es) Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana.
MXPA03010790A (es) Heterociclos biciclicos que contienen nitrogeno para uso como antibacterianos.
GB9822440D0 (en) Medicaments
WO2001007432A8 (en) Aminopiperidine derivatives as antibacterials
AU2003291227A1 (en) Antibacterial agents
AU2002218192A1 (en) Quinoline derivatives as antibacterials
GB9822450D0 (en) Medicaments
WO2003064431A3 (en) Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
TW200507841A (en) Antibacterial agents
EP1560821B8 (en) Antibacterial agents
CA2366304A1 (en) Novel method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)